BMJ Sexual & Reproductive Health最新文献_第9页

Views and experiences of long-acting reversible contraception among ethnic minorities in high-income countries: a systematic review of qualitative studies. 高收入国家少数民族对长效可逆避孕的看法和经验：定性研究的系统综述。

IF 3.3 3区医学

BMJ Sexual & Reproductive Health Pub Date : 2024-01-09 DOI: 10.1136/bmjsrh-2023-201864

Sumayyah Ahmed, Abigail McLoughlin Dymond, Michele Correa, Merlin L Willcox

{"title":"Views and experiences of long-acting reversible contraception among ethnic minorities in high-income countries: a systematic review of qualitative studies.","authors":"Sumayyah Ahmed, Abigail McLoughlin Dymond, Michele Correa, Merlin L Willcox","doi":"10.1136/bmjsrh-2023-201864","DOIUrl":"10.1136/bmjsrh-2023-201864","url":null,"abstract":"BackgroundEthnic minorities in high-income countries have higher rates of unintended pregnancies but are less likely to use highly efficacious long-acting reversible contraception (LARC). The reasons for this are unclear.Aim: To understand the views and experiences of ethnic minorities within high-income countries about LARC.Methodology: Medline, CINAHL, EMBASE and Sociological Abstracts were searched systematically to find qualitative articles about views on LARC. Titles and abstracts were screened to select qualitative studies about LARC whose participants were mainly from ethnic minorities in high-income countries. Quality assessment was conducted using the Critical Appraisal Skills Programme (CASP) tool. Thematic synthesis was conducted.Results: Seventeen studies (19 articles) met the inclusion criteria, 14 of which were from the USA (227 participants identified as Latina, 222 Black, 15 multiracial, 4 Asian). Two studies included 32 Chinese women in the UK and Australia and one included 20 Aboriginal women in Australia. Factors influencing uptake of LARC included side effects, convenience, and perceived efficacy of LARC compared with other methods; women's ideas, concerns and expectations; and external influences (partner, family/friends, health professionals and society). Convenience of LARC, control over reproductive decisions, and desire to prevent pregnancy were the main facilitators. Barriers included specific cultural concerns about irregular bleeding, concerns about racial discrimination, and family/friends having negative views on LARC.Conclusions: Ethnic minority women often have additional needs and concerns about LARC compared with the White majority. Further research is needed to develop and evaluate customised respectful counselling on contraception options for ethnic minority women and their partners.","PeriodicalId":9219,"journal":{"name":"BMJ Sexual & Reproductive Health","volume":" ","pages":"53-66"},"PeriodicalIF":3.3,"publicationDate":"2024-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72208472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Going with the flow: the emergence of menstrual science. 顺其自然：月经科学的出现。

IF 3.3 3区医学

BMJ Sexual & Reproductive Health Pub Date : 2024-01-09 DOI: 10.1136/bmjsrh-2023-201972

Nichole Tyson, Olga Kciuk, Paul D Blumenthal

引用次数: 0

Highlights from literature. 来自文学的亮点。

IF 3.3 3区医学

BMJ Sexual & Reproductive Health Pub Date : 2024-01-09 DOI: 10.1136/bmjsrh-2023-202104

引用次数: 0

Contraceptive efficacy and global licensing of 52 mg levonorgestrel intrauterine devices: does a Mirena last longer in New York than York? 52 毫克左炔诺孕酮宫内节育器的避孕效果和全球许可：Mirena 在纽约的使用时间比约克长吗？

IF 3.3 3区医学

BMJ Sexual & Reproductive Health Pub Date : 2024-01-09 DOI: 10.1136/bmjsrh-2023-201937

Zachary Nash, Annette Thwaites

引用次数: 0

Patterns in the provision of government-subsidised hormonal postpartum contraception in Queensland, Australia between 2012 and 2018: a population-based cohort study. 2012年至2018年澳大利亚昆士兰州政府补贴激素产后避孕药具的提供模式：一项基于人群的队列研究。

IF 3.3 3区医学

BMJ Sexual & Reproductive Health Pub Date : 2024-01-09 DOI: 10.1136/bmjsrh-2023-201830

Alayna Carrandi, Claudia Bull, Yanan Hu, Luke E Grzeskowiak, Helena Teede, Kirsten Black, Emily Callander

{"title":"Patterns in the provision of government-subsidised hormonal postpartum contraception in Queensland, Australia between 2012 and 2018: a population-based cohort study.","authors":"Alayna Carrandi, Claudia Bull, Yanan Hu, Luke E Grzeskowiak, Helena Teede, Kirsten Black, Emily Callander","doi":"10.1136/bmjsrh-2023-201830","DOIUrl":"10.1136/bmjsrh-2023-201830","url":null,"abstract":"Background: Short birth intervals and unintended pregnancy are associated with poorer maternal and infant outcomes. There is a risk of pregnancy during the immediate postpartum period unless contraception is initiated. This retrospective cohort study aimed to capture the current patterns of hormonal contraceptive provision within 12 months postpartum in a high-income country.Methods: We used a linked administrative dataset comprising all women who gave birth in Queensland, Australia between 1 July 2012 and 30 June 2018 (n=339 265 pregnancies). We described our cohort by whether they were provided with government-subsidised hormonal contraception within 12 months postpartum. The associations between hormonal postpartum contraceptive provision and demographic and clinical characteristics were examined using univariate and multivariate logistic regression and presented in terms of crude and adjusted odds ratios with 95% confidence intervals.Results: A majority of women (60.2%) were not provided with government-subsidised hormonal postpartum contraception within 12 months postpartum. Women who were younger (<25 years), were overweight or obese, smoked, were born in Australia, were non-Indigenous, gave birth in a public hospital, or were in the lowest socioeconomic status group were more likely to be provided with postpartum contraception after adjusting for other covariates, compared with their counterparts.Conclusions: Strategies to increase the provision and uptake of contraception in the immediate postpartum period are needed to prevent short birth intervals and unintended pregnancy and ensure women's fertility intentions are enacted. Ongoing research is needed to examine the factors influencing women's access to contraceptive services and, further, the types of contraception provided.","PeriodicalId":9219,"journal":{"name":"BMJ Sexual & Reproductive Health","volume":" ","pages":"13-20"},"PeriodicalIF":3.3,"publicationDate":"2024-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10035380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Time to treat the climate and nature crisis as one indivisible global health emergency. 是时候将气候和自然危机视为一个不可分割的全球卫生紧急事件了。

IF 3.3 3区医学

BMJ Sexual & Reproductive Health Pub Date : 2023-10-25 DOI: 10.1136/bmjsrh-2023-202111

Chris Zielinski

引用次数: 0

Highlights from the literature. 文献亮点。

IF 3.3 3区医学

BMJ Sexual & Reproductive Health Pub Date : 2023-10-18 DOI: 10.1136/bmjsrh-2022-201747

引用次数: 0

Self-care for abortion activists and providers: lessons of law and risk from Argentina. 堕胎活动家和提供者的自我护理：阿根廷的法律和风险教训。

IF 3.3 3区医学

BMJ Sexual & Reproductive Health Pub Date : 2023-10-01 Epub Date: 2023-05-23 DOI: 10.1136/bmjsrh-2023-201847

Raquel Irene Drovetta, Cordelia Freeman, Agustina Rúa

引用次数: 1

Understanding barriers to using long-acting reversible contraceptives (LARCs) in primary care: a qualitative evidence synthesis. 了解在初级保健中使用长效可逆避孕药的障碍：定性证据综合。

IF 3.3 3区医学

BMJ Sexual & Reproductive Health Pub Date : 2023-10-01 Epub Date: 2023-02-21 DOI: 10.1136/bmjsrh-2022-201560

Emma Linton, Rebecca Mawson, Victoria Hodges, Caroline Anne Mitchell

{"title":"Understanding barriers to using long-acting reversible contraceptives (LARCs) in primary care: a qualitative evidence synthesis.","authors":"Emma Linton, Rebecca Mawson, Victoria Hodges, Caroline Anne Mitchell","doi":"10.1136/bmjsrh-2022-201560","DOIUrl":"10.1136/bmjsrh-2022-201560","url":null,"abstract":"Background: Long-acting reversible contraceptives (LARCs) are highly effective. In primary care, LARCs are prescribed less frequently than user-dependent contraceptives despite higher efficacy rates. Unplanned pregnancies are rising in the UK, and LARCs may have a role in reducing these through and redressing inequitable contraceptive access. To provide contraceptive services that offer maximal choice and patient benefit, we must understand what contraception users and healthcare professionals (HCPs) think about LARCs and uncover barriers to their use.Methods: A systematic search using CINAHL, MEDLINE via Ovid, PsycINFO, Web of Science and EMBASE identified research about LARC use for pregnancy prevention in primary care. The approach adhered to the 'Preferred Reporting Items for Systematic Reviews and Meta-Analyses' methodology, critically appraised the literature, and used NVivo software to organise data and perform thematic analysis to determine key themes.Results: Sixteen studies met our inclusion criteria. Three themes were identified: (1) trustworthiness (where and from whom participants obtained information regarding LARCs), (2) control (whether LARCs detract from personal autonomy) and (3) systems (how HCPs influenced LARC access). Misgivings about LARCs frequently arose from social networks and fears of surrendering control over fertility were prominent. HCPs perceived access issues and lack of familiarity or training as the main barriers to prescribing LARCs.Conclusions: Primary care plays a key role in improving access to LARC but barriers need to be addressed especially those involving misconception and misinformation. Access to LARC removal services are key to empower choice and prevent coercion. Facilitating trust within patient-centred contraceptive consult is essential.","PeriodicalId":9219,"journal":{"name":"BMJ Sexual & Reproductive Health","volume":" ","pages":"282-292"},"PeriodicalIF":3.3,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10759208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3

You're invited: welcome to the dynamic world of quality improvement and implementation science. 我们邀请您：欢迎来到充满活力的质量改进和实施科学世界。

IF 3.3 3区医学

BMJ Sexual & Reproductive Health Pub Date : 2023-10-01 Epub Date: 2023-04-11 DOI: 10.1136/bmjsrh-2023-201814

Lisa M Goldthwaite, Cati G Brown-Johnson

引用次数: 0